UK pharma major AstraZeneca and Japanese drugmaker Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has won conditional approval in China as a monotherapy for the treatment of adult patients with ...
The FDA has approved new 2mL pre-filled syringes and autoinjectors for UCB's Bimzelx (bimekizumab-bkzx) to treat psoriasis. Each contains 320mg, offering single-injection options alongside existing ...